These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity. Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747 [TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors. Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269 [TBL] [Abstract][Full Text] [Related]
10. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors]. Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306 [TBL] [Abstract][Full Text] [Related]
11. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor. Heuillet E; Petitet F; Mignani S; Malleron JL; Lavayre J; Néliat G; Doble A; Blanchard JC Eur J Pharmacol; 1996 Oct; 314(1-2):229-33. PubMed ID: 8957240 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the novel antipsychotic iloperidone at human D2, D3, alpha 2C, 5-HT6, and 5-HT1A receptors. Kalkman HO; Feuerbach D; Lötscher E; Schoeffter P Life Sci; 2003 Jul; 73(9):1151-9. PubMed ID: 12818723 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif. Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944 [TBL] [Abstract][Full Text] [Related]
14. From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon. Okun I; Tkachenko SE; Khvat A; Mitkin O; Kazey V; Ivachtchenko AV Curr Alzheimer Res; 2010 Mar; 7(2):97-112. PubMed ID: 19939222 [TBL] [Abstract][Full Text] [Related]
15. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market? Albers LJ; Musenga A; Raggi MA Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919 [TBL] [Abstract][Full Text] [Related]
16. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322 [TBL] [Abstract][Full Text] [Related]
17. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease. Scheller D; Ullmer C; Berkels R; Gwarek M; Lübbert H Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):73-86. PubMed ID: 18704368 [TBL] [Abstract][Full Text] [Related]
18. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Lawler CP; Prioleau C; Lewis MM; Mak C; Jiang D; Schetz JA; Gonzalez AM; Sibley DR; Mailman RB Neuropsychopharmacology; 1999 Jun; 20(6):612-27. PubMed ID: 10327430 [TBL] [Abstract][Full Text] [Related]
19. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone. Mutlib AE; Klein JT J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390 [TBL] [Abstract][Full Text] [Related]
20. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone. Mutlib AE; Strupczewski JT; Chesson SM Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]